Clinical Trials
All Clinical Trials - Page 33 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02847403Phase 3Unknown
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
Exenatide
- NCT02685852Phase 1Completed
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
Exenatide
- NCT02673931N/AActive Not Recruiting
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
Exenatide
- NCT02501161Phase 3Completed
A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT02533453Phase 4Completed
A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.
Exenatide
- NCT02648204Phase 3Completed
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
Semaglutide
- NCT06133946N/AActive Not Recruiting
Cohort Of DEafness-gene Screening
MOTS-c
- NCT02381821N/ACompleted
Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success
Gonadorelin
- NCT02542930Phase 2Withdrawn
Abscopal Effect for Metastatic Non-small Cell Lung Cancer.
Thymosin-Alpha-1
- NCT02545751Phase 2Unknown
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Thymosin-Alpha-1
- NCT02705014N/AUnknown
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
Gonadorelin
- NCT02626507Phase 1Unknown
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Gonadorelin
- NCT02635607N/AUnknown
Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol
Gonadorelin
- NCT02832999Phase 4Completed
Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
Liraglutide
- NCT02650596N/AUnknown
Effects of GLP-1 on Chronic Heart Failure
Liraglutide
- NCT02650479Phase 1Completed
Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
Exenatide
- NCT02597777N/ACompleted
Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin
Argireline
- NCT02607293N/ACompleted
A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
Gonadorelin
- NCT02647944Phase 2Completed
Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
Liraglutide
- NCT02544191Phase 2Unknown
GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia
Gonadorelin
- NCT02678520Phase 2Withdrawn
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients
Gonadorelin
- NCT02611232Phase 2Unknown
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
Liraglutide
- NCT02638805Phase 3Completed
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Liraglutide
- NCT02496611Phase 2Completed
Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
Exenatide
- NCT02641899Phase 1Completed
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
Exenatide
- NCT02621489Phase 4Completed
Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
Exenatide
- NCT02641990Phase 1Completed
Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects
Exenatide
- NCT02531516Phase 3Active Not Recruiting
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Gonadorelin
- NCT02602600Phase 4Completed
Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
Liraglutide
- NCT02607306Phase 3Completed
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
Liraglutide
- NCT03889496N/ATerminated
Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
Exenatide
- NCT02443155Phase 2Completed
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
Liraglutide
- NCT02527200Phase 3Completed
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
Liraglutide
- NCT03162042N/ACompleted
Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers
Follistatin
- NCT03534310N/ACompleted
Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
Liraglutide
- NCT02605226N/AUnknown
Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer
Gonadorelin
- NCT03010683N/ACompleted
Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
Liraglutide
- NCT02617654Phase 2Completed
Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
Liraglutide
- NCT02597049Phase 3Completed
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT02449603Phase 4Completed
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
Exenatide
- NCT02584075Phase 4Unknown
Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function
Exenatide
- NCT02251431Phase 3Completed
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
Exenatide
- NCT02453711Phase 2Completed
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
Semaglutide
- NCT02637284Phase 1Unknown
PCO-02 - Safety and Pharmacokinetics Trial
BPC-157
- NCT02592083Phase 2Active Not Recruiting
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Gonadorelin
- NCT02527993Phase 4Completed
Treatment of Hypoglycemia Following Gastric Bypass Surgery
Liraglutide
- NCT02577848N/AUnknown
GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
Liraglutide
- NCT02461589Phase 2Completed
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
Semaglutide
- NCT02381288Phase 2Terminated
Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone
Kisspeptin
- NCT02597803Phase 2/Phase 3Completed
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
TB-500